ID   A549 MIR1343 KO
AC   CVCL_C3IT
SY   miR-1343Delta A549
DR   cancercelllines; CVCL_C3IT
DR   GEO; GSM2635908
DR   GEO; GSM2635910
DR   GEO; GSM2635913
DR   Wikidata; Q114310528
RX   PubMed=29022142;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 41902; MIR1343.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 5
//
RX   PubMed=29022142; DOI=10.1007/s00441-017-2697-6;
RA   Stolzenburg L.R., Harris A.;
RT   "Microvesicle-mediated delivery of miR-1343: impact on markers of
RT   fibrosis.";
RL   Cell Tissue Res. 371:325-338(2018).
//